title: Z944: a first in class T-type calcium channel modulator for the treatment of pain.
authors.affiliation: Research Translational Medicine, Zalicus, Inc., Cambridge, MA, USA.
authors.forename: M
authors.initials: M
authors.lastname: Lee
mesh_terms: D000081:Acetamides / Q000494:pharmacology / Q000627:therapeutic use; D000284:Administration, Oral; D001549:Benzamides / Q000494:pharmacology / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use*; D002211:Capsaicin / Q000009:adverse effects; D017321:Clinical Trials, Phase I as Topic; D004305:Dose-Response Relationship, Drug; D005073:Evoked Potentials, Somatosensory / Q000187:drug effects; D006801:Humans; D007834:Lasers / Q000009:adverse effects; D008297:Male; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010880:Piperidines; D013997:Time Factors
chemical_list: D000081:Acetamides; D001549:Benzamides; D002121:Calcium Channel Blockers; D010880:Piperidines; C000629485:Z944; D002211:Capsaicin